Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

236 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Anti-spike IgG4 and Fc effector responses: The impact of SARS-CoV-2 vaccine platform-specific priming and immune imprinting.
Kalkeri R, Zhu M, Cloney-Clark S, Parekh A, Gorinson D, Cai Z, Cai MR, Mahato S, Chau G, Babu TM, Wald A, Ramanathan P, Aurelia LC, Selva KJ, Marchese AM, Fries L, Dunkle LM, Chung AW, Plested JS. Kalkeri R, et al. Among authors: chau g. J Infect. 2025 Jun 26;91(2):106543. doi: 10.1016/j.jinf.2025.106543. Online ahead of print. J Infect. 2025. PMID: 40581329 Free article.
Safety and immunogenicity of Omicron protein vaccines in mRNA-vaccinated adolescents: A phase 3, randomised trial.
Bennett C, Chau G, Clayton E, Chu L, Alvarez J, Hidalgo AB, Palanpurwala K, Plested JS, Zhu M, Cloney-Clark S, Cai Z, Kalkeri R, Hegazy K, Smith K, Neal S, Noriega F, Mallory RM, Adelglass JM; 2019nCoV-314 Study Investigators. Bennett C, et al. Among authors: chau g. J Infect. 2025 Feb;90(2):106428. doi: 10.1016/j.jinf.2025.106428. Epub 2025 Jan 26. J Infect. 2025. PMID: 39874991 Free article. Clinical Trial.
Immunogenicity and safety of a fourth homologous dose of NVX-CoV2373.
Alves K, Plested JS, Galbiati S, Chau G, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Smith K, Marcheschi A, Pfeiffer S, McFall H, Smith G, Glenn GM, Dubovsky F, Mallory RM; Novavax 2019nCoV-101 Study Group. Alves K, et al. Among authors: chau g. Vaccine. 2023 Jun 29;41(29):4280-4286. doi: 10.1016/j.vaccine.2023.05.051. Epub 2023 Jun 2. Vaccine. 2023. PMID: 37271706 Free PMC article. Clinical Trial.
Immunogenicity of a Fourth Homologous Dose of NVX-CoV2373.
Alves K, Plested JS, Galbiati S, Chau G, Cloney-Clark S, Zhu M, Kalkeri R, Patel N, Smith K, Marcheschi A, Pfeiffer S, McFall H, Smith G, Glenn GM, Dubovsky F, Mallory RM; Novavax 2019nCoV-101 Study Group. Alves K, et al. Among authors: chau g. N Engl J Med. 2023 Mar 2;388(9):857-859. doi: 10.1056/NEJMc2215509. Epub 2023 Jan 25. N Engl J Med. 2023. PMID: 36734884 Free PMC article. No abstract available.
Strong CD4+ T-Cell Responses to Ancestral and Variant Spike Proteins Are Established by NVX-CoV2373 Severe Acute Respiratory Syndrome Coronavirus 2 Primary Vaccination.
Fries L, Formica N, Mallory RM, Zhou H, Plested JS, Kalkeri R, Moldovan I, Patel N, Albert G, Robinson M, Cho I, Chau G, Dubovsky F, Glenn GM; 2019nCoV-101 Study Group. Fries L, et al. Among authors: chau g. J Infect Dis. 2023 Sep 15;228(6):734-741. doi: 10.1093/infdis/jiad163. J Infect Dis. 2023. PMID: 37210741 Free PMC article. Clinical Trial.
Safety, efficacy, and immunogenicity of the NVX-CoV2373 vaccine.
Underwood E, Dunkle LM, Madhi SA, Gay CL, Heath PT, Kotloff KL, Smith K, Chau G, Galbiati S, McGarry A, Woo W, Cho I, Alves K, Áñez G, Bennett C, Shinde V, Fries L, Mallory RM, Glenn GM, Toback S. Underwood E, et al. Among authors: chau g. Expert Rev Vaccines. 2023 Jan-Dec;22(1):501-517. doi: 10.1080/14760584.2023.2218913. Expert Rev Vaccines. 2023. PMID: 37246757 Free article. Review.
Tuberculosis disease characteristics associated with mortality, severe morbidity and unsuccessful treatment in people living with HIV treated for tuberculosis - a secondary analysis of the ANRS 12300 Reflate TB2 trial.
Akpata R, Ntakpe JB, Messou E, De Castro N, Chazallon C, Timana I, Escada R, Cardoso SW, Bhatt N, Khosa C, Laureillard D, Do Chau G, Nogbou FE, Glao DD, Veloso V, Molina JM, Grinsztejn B, Zannou M, Eholie S, Marcy O; ANRS 12300 Reflate TB2 study Consortium. Akpata R, et al. Among authors: do chau g. BMC Infect Dis. 2025 May 14;25(1):695. doi: 10.1186/s12879-025-10986-4. BMC Infect Dis. 2025. PMID: 40361016 Free PMC article. Clinical Trial.
236 results